HOME > R&D > PIPELINES

Our pipeline includes FDA approved antibiotic, Factive and other drug candidates in clinical and preclinical stages such as hGH, IFN-a, HBV treatment, caspase inhibitor, SR-IFNa, and oral thrombin inhibitors.

Pipeline 1. New Chemical Entities

Therapeutic
Area
Compound/
Product
Type Indication DS PC Clinical Trial NDA M Note
Infectious
Disease
Factive® DNA Rep.
Inhibitor
CAP,AECB/ABS             US FDA/KFDA
approved
Otitis media              
LB80380 DNA Pol
Inhibitor
Hepatitis B              
LB84451 Caspase
Inhibitor
Hepatitis C             Licensed to Gilead
Metabolic
Disease
LC15-0444 DPP IV
Inhibitor
Type 2
Diabetes
             
  GK Activator Type 2
Diabetes
             
  - Obesity             Collaboration
with Takeda
  Cell
Protectant
Cell
protection
             
CV Disease   PAR-1
Inhibitor
Atherothrombosis              
  P2Y12
Inhibitor
Atherothrombosis              
Others   Xanthine
Oxidase
Gout              
Uritos Muscarinic
Inhibitor
Urinary
Incontinence
            Licensed
from Kyorin
  • CAP: Community Acquired Pneumonia
  • AECB: Acute Exacerbation of Chronic Bronchitis
  • ABS: Acute Bacterial Sinusitis
  • NASH: Non-Alcoholic Steatohepatitis
  • IPF: Idiopathic Pulmonary Fibrosis
  • DPP: Dipeptidyl Peptidase
  • GK: Glucokinase

Pipeline 2. Bio Pharmaceuticals & Medical Device

Class Product Indication DS PC Clinical Trial NDA M Note
Biogeneric hGH Valtropin® GHD, TS/CRI             US FDA/EMEA approved
Eutropin® GHD, TS/CRI             Domestic market
SGA              
EPO (Espogen®) Anemia of CRF             Cultured in roller bottle
Anemia of CRF             Cultured in bioreactor
rFSH (Follitrope®) IVF              
Anovulation              
Long Acting
Product
SR-hGH LB03002 Adult & Pediatric GHD             Global market
Declage® Adult GHD             Domestic market
Eutropin Plus® Pediatric GHD             Domestic market
SR-IFNα Hepatitis C              
SR-Exendin Type 2 Diabetes              
Antibody Amevive Psoriasis             Licensed
from Astellas
TNFmab Rheumatoid
Arthritis
             
TNFcept Rheumatoid
Arthritis
             
LBRx Rheumatoid
Arthritis
             
Vaccine DTaP-HepB D/T/P/HBV prevention             Partnered with
Kaketsuken
DTwP-HepB D/T/P/HBV prevention             Partnered with
BB-NCIPD
Hib Meningitis              
Medical
Device
HA Mesoglow Skin Rejuvenation              
HA IDF Skin Rejuvenation              
Esthelis Skin Rejuvenation             Licensed from
Anteis S.A
  • GHD: Growth Hormone Deficiency
  • TS: Turner’s Syndrom
  • CRI: Chronic Renal Insufficiency
  • SGA: Small for Gestational Age
  • SR: Sustained Released
  • CRF: Chronic Renal Failure
  • IVF: In vitro Fertilization
  • CML: Chronic Myeloid Leukemia
  • HA: Hyaluronic Acid
  • IDF: Injectable Dermal Filler

Pipeline 3. Generic / Branded Generic

Therapeutic
Area
Compound/
Product
Indication IND
(or CA)
Clinical Trial
(BE test included)
NDA
(or MA)
M Note
CV
Disease
Pioglitazone
(Pioglizone ®)
Type 2
Diabetes
           
CV-1 Hyperlipidemia            
CV-2 Hypertension            
Urological
Disease
Tolterodine
(Tolteros SR ®)
Urinary
Incontinence
           
Tamsulosin BPH            
Tamsulosin
+finasteride
BPH            
Musculoskeletal
Diasase
Dualcet Chronic pain            
OS-1
(Posnyl ®)
Osteoporosis            
OS-2
(morniflumate)
NSAIDS            
Oncology Megestrol
Suspension
(Apetrol ®)
Anorexia            
Casodex
(Casdel ®)
Prostate
cancer
           
Sancuso ® Emesis
patch
           
Imatinb Breast
cancer
           
  • CA : Conditional Approval
  • MA : Market Approval
  • BE : Bioequivalence
  • BPH : Benign Prostatic Hyperplasia

Pipeline 4. Diagnostics

Area Type Product Indication DS PC CT MA M Note
Molecular
Diagnostics
Real-time
PCR
AdvanSure TB/NTM
real time PCR®
Tuberculosis          
AdvanSure HPV 16/18
real time PCR®
Cervical Cancer          
AdvanSure CT/NG
real time PCR®
Chlamydia/
Gonorrhoeae
         
AdvanSure HCV
real time PCR®
Hepatitis C          
AdvanSure HPV
screening PCR®
Cervical Cancer          
AdvanSure HCV
monitoring real time PCR®
Hepatitis C          
AdvanSure HBV
monitoring real time PCR®
Hepatitis B          
Blood NAT
Screen
Hepatitis/AIDS          
DNA chip AdvanSure Mycobacteria
genotyping chip®
Tuberculosis          
AdvanSure TB MDR Tuberculosis          
Immunoblot AdvanSure
Allergy Screen®
Immunoglobulin E          
  • TB : Tuberculosis
  • NTM : Non-tuberculous Mycobacteria
  • HPV : Human Papiloma Virus
  • CT : Chlamydia Trachomatis
  • NG : Neisseria Gonorrhoeae